
    
      All patients receive Alemtuzumab in 3 successive phases:

      Phase A: Test week: 3mg, then 10mg, then 30mg every other day for one week to test for
      tolerance.

      Phase B: 30mg 3 times a week for 12 to 18 administrations until response or
      progression/failure has been documented.

      Phase C: in patients in CR, maintenance with Alemtuzumab: 3 injections one week every 2
      months.
    
  